danaher investor presentation 2022

Press Releases

Danaher reports first quarter 2024 results.

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 29, 2024. All results in this release reflect only continuing operations unless otherwise noted....

Danaher Schedules First Quarter 2024 Earnings Conference Call

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, April 23, 2024 beginning at 8:00 a.m. ET and lasting...

Danaher to Present at TD Cowen Health Care Conference

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday,...

Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets

Danaher Corporation (NYSE: DHR) (Danaher) announced today it has committed to set science-based greenhouse gas (GHG) emission reduction targets in line with the Science Based Targets initiative...

Danaher Announces Quarterly Dividend

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on April 26, 2024 to...

Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development

Danaher Beacon for Preclinical Drug Safety seeks to address major cause of failure in clinical trials Program will leverage automated liver organoid technology for drug toxicity screening Aims to...

Danaher Reports Fourth Quarter and Full Year 2023 Results

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2023. All results in this release reflect only continuing operations unless otherwise...

Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution

New collaborative research center based at University of California, Berkeley, plans to develop platform approaches that can be easily modified to develop gene-editing medicines for hundreds of...

Danaher CEO to Comment on Financial Performance

Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2023 performance in...

Danaher to Present at J.P. Morgan Healthcare Conference

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on...

Danaher Schedules Fourth Quarter 2023 Earnings Conference Call

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2023 on Tuesday, January 30, 2024 beginning at 8:00 a.m. ET and lasting...

Danaher Completes Acquisition of Abcam

Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The acquisition of Abcam for $24.00 per share in cash was...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.24 per share of its common stock, payable on January 26, 2024 to...

Danaher to Present at Evercore ISI HealthCONx Conference

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conference in Miami, Florida on Wednesday,...

Danaher appoints Christopher Riley to Executive Vice President for Biotechnology

Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, today announced that Christopher Riley has been appointed by its Board of...

Danaher Reports Third Quarter 2023 Results

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the third quarter ended September 29, 2023. Net earnings refer to net earnings attributable to common shareholders....

Danaher Corporation Completes Separation of Veralto Corporation

Danaher Corporation (NYSE: DHR) announced today that it has completed the separation of its Environmental & Applied Solutions segment, through the spin-off of Veralto Corporation. Veralto will...

Danaher Schedules Third Quarter 2023 Earnings Conference Call

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2023 on Tuesday, October 24, 2023 beginning at 8:00 a.m. ET and lasting...

Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost

New agreement aims to provide greater access to millions more high-quality tuberculosis (TB) tests for people living in the least developed countries where the need is most urgent. Enables the...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on October 27, 2023 to...

Danaher and Veralto to Webcast Investor and Analyst Meeting

Danaher Corporation (NYSE: DHR) will host a live video webcast of Veralto's Investor and Analyst Meeting on September 6, 2023 beginning at approximately 12:00 p.m. CT. The event, which will...

Danaher to Acquire Abcam

Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Abcam plc...

Danaher Declares pro Rata Dividend of Veralto Common Stock and Announces Expected "When-issued" Trading of Veralto Common Stock

Danaher Corporation (NYSE: DHR) today announced that it expects to complete the previously announced separation of Veralto Corporation on September 30, 2023, the first day of Danaher's fiscal...

Danaher Releases 2023 Sustainability Report

Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), the global science and technology innovator, today published its 2023 Sustainability Report which conveys the depth and scope of...

Danaher Reports Second Quarter 2023 Results

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the second quarter 2023. Net earnings refer to net earnings attributable to common shareholders. For the quarter ended...

Danaher Schedules Second Quarter 2023 Earnings Conference Call

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2023 on Tuesday, July 25, 2023 beginning at 8:00 a.m. ET and lasting...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on July 28, 2023 to...

Danaher to Present at Bank of America Securities Health Care Conference

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas,...

Danaher Reports First Quarter 2023 Results

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the first quarter 2023. Net earnings refer to net earnings attributable to common shareholders. For the quarter ended...

Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock

Danaher Corporation (NYSE: DHR) announced today that its 5.00% Series B Mandatory Convertible Preferred Stock (the "Preferred Stock"), will automatically convert into shares of the Company's...

Danaher Schedules First Quarter 2023 Earnings Conference Call

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2023 on Tuesday, April 25, 2023 beginning at 8:00 a.m. ET and lasting...

Danaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies

Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced a strategic partnership with the University of Pennsylvania (Penn) focusing on cell therapy innovation....

Danaher Announces Quarterly Dividends

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on April 28, 2023 to...

Danaher Announces New Environmental and Applied Solutions Company to Be Named Veralto

Danaher Corporation (NYSE: DHR) ("Danaher") today announced that Veralto Corporation ("Veralto" or the "Company") will be the name of the separate public company Danaher intends to create in the...

Danaher Reports Fourth Quarter and Full Year 2022 Results

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2022. All results in this release reflect only continuing operations unless otherwise...

Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2022 performance in...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at...

Danaher Schedules Fourth Quarter 2022 Earnings Conference Call

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2022 on Tuesday, January 24, 2023 beginning at 8:00 a.m. ET and lasting...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.25 per share of its common stock, payable on January 27, 2023 to...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conference on Wednesday, November 30, 2022...

Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation

Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for...

Danaher Reports Third Quarter 2022 Results

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the third quarter 2022. All results in this release reflect only continuing operations unless otherwise noted. For the...

Danaher Releases 2022 Sustainability Report and Announces New Greenhouse Gas Emissions Reduction Target

Danaher Corporation (NYSE: DHR) (the "Company"), the global science and technology innovator, today published its 2022 Sustainability Report which highlights the progress of the Company's...

Danaher Schedules Third Quarter 2022 Earnings Conference Call

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2022 on Thursday, October 20, 2022 beginning at 8:00 a.m. ET and lasting...

Danaher Announces Intention to Separate Environmental & Applied Solutions Segment to Create an Independent, Publicly Traded Company

Danaher Corporation (NYSE: DHR) today announced its intention to separate its Environmental & Applied Solutions segment to create an independent, publicly traded company. The new company will be...

Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's third quarter 2022 performance in...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.25 per share of its common stock, payable on October 28, 2022 to...

Danaher to Webcast Bioprocessing Investor and Analyst Meeting at Cytiva

Danaher Corporation (NYSE: DHR) will host a live video webcast of its Bioprocessing Investor and Analyst Meeting at Cytiva on September 15, 2022 beginning at approximately 12:00 p.m. ET. The event...

Danaher Reports Second Quarter 2022 Results

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the second quarter 2022. All results in this release reflect only continuing operations unless otherwise noted. For the...

Danaher Announces Appointment of Feroz Dewan to Danaher Board

Danaher Corporation (NYSE: DHR) announced today that it has appointed Feroz Dewan to its Board of Directors and to the Board's Science & Technology Committee. This addition expands the size of...

• SUBSCRIPTION SERVICES
• EDITORIAL CALENDAR
• EVENTS / WEBINARS
• INDUSTRY LINKS
• BUYERS DIRECTORY

Ilim Group Increased Corrugated Board Output by 9% in 2021

Feb. 10, 2022 - Ilim Group announced that its corrugated box plants — Dmitrov and Kommunar — delivered a record-high volume of 282 million square meters (131 thousand tons) of products in 2021.

Ilim noted that it has increased the output of corrugated board in 2021 by 9% compared to 2020 and, over the last three years, the company's corrugated box business has been demonstrating high growth rates of about 10% per year.

In 2021, EBIDTA of Ilim Group corrugated box plants totaled USD 16.3 million, which is 2.2 times higher vs. 2020, driven by prices for corrugated products as well as finished products output supported by reduction of losses.

"The past year saw the most successful performance of Ilim's corrugated box plants of all time," said Vladimir Shoshin, Director, Packaging Sales, Ilim Group. "When preparing our plans for 2021, we understood that competition pressure in the corrugated materials market will grow as well as feedstock prices.

"Expansion of the company's customer base in the end of 2020, followed by an increase in the number of orders, allowed our box plants to increase their production volumes already in the beginning of 2021," Shoshin explained.

Corrugated box plants in Dmitrov and Kommunar are a part of Ilim Group's vertically integrated production process. In 2021, Ilim's box plants consumed 71% of its own feedstock, which enables the company to ensure full control over production process and avoid disruption in supplies.

Pavel Alekseev, Operations Director, Packaging Business, Ilim Group, added, "Today, the key drivers of the corrugated materials market development include active development of e-commerce, global 'going green' trends as well as conscious consumption."

According to Ilim Group estimates, the demand for corrugated products will grow by 4-5% in 2022.

Ilim's Corrugated Plants

Ilim Group has two corrugated box plants in the Leningrad (Kommunar) and Moscow (Dmitrov) Oblasts. The plants produce several types of products, including transportation, retail and industrial packaging, corrugated trays as well as packaging for posting items and e-commerce. In 2021, Ilim Gofra was named the winner of the international PART Award.

Ilim Group is the largest manufacturer of pulp and paper products in Russia, and one of the largest exporters of softwood pulp to China. Ilim has three pulp and paper mills in the Arkhangelsk (Koryazhma) and Irkutsk (Bratsk, Ust-Ilimsk) Oblasts, two modern corrugated box plants in the Leningrad and Moscow Oblasts, and Sibgiprobum engineering and design institute (Irkutsk). To learn more, visit: www.ilimgroup.com .

SOURCE: Ilim Group

Paper Industry Newsletter Stay on top of paper industry news from around the world with PaperAge's free weekly newsletter. Delivered every Thursday. Sign up today!

• Subscription Services
• Editorial Calendar
• Media Guide
• Events / Webinars
• Industry Links
• Buyers Directory
• About PaperAge

PaperAge PO Box 904, Cohasset, MA 02025 (USA) Phone: 781-378-1253

Editorial Contact – Print, Website, Newsletter John O'Brien, Managing Editor Phone: 781-536-4925 email: [email protected]

Advertising Sales – Print and Digital Michael O'Brien, Publisher Phone: 781-378-1253 email: [email protected]

PaperAge. Copyright © O'Brien Publications, Inc. All rights reserved.

• HYDROVISION
• Career Center

En+ Group to replace six units at 4.5-GW Bratsk hydropower plant

En+ Group announces it has begun replacing six hydraulic units at the its 4.5-GW Bratsk hydropower plant , on the Angara River in Russia, as part of its “New Energy” modernization program.

The total investment for this stage of the project is more than RUB1.5 billion (US$20.3 million). The work is planned to take place from 2021 to 2026 and will result in replacement of all 18 impellers (12 were replaced during the earlier stages of the modernization program in 2007 to 2010 and 2014 to 2017).

En+ Group says it is the world’s leading producer of low-carbon aluminum and largest private sector generator of hydropower .

Specialists from the Bratsk HPP and LLC EuroSibEnergo-Hydrogeneration oversaw laboratory tests on the new hydro turbine model, as well as on its operation in various load modes. Turbine and impeller models of the hydraulic unit were developed and manufactured at a scale of 1:10 for the tests. Tests included a sample view of measuring transducers, determining the efficiency and power of the units, cavitation and acceleration tests, video surveillance of the flow structure, and random tests on individual elements of the hydro turbine’s flow part. These tests suggest that the efficiency of the new hydro turbine will be 96.51%, which is almost 5% higher than the performance of existing hydroelectric units.

“We are continuing our work under the “New Energy” program at all of our hydroelectric power plants in 2021,” said Mikhail Hardikov, head of En+ Group’s energy sector. “The results obtained during the first stages of the program have already justified our investment in the project. All 12 new impellers at the Bratsk HPP have already demonstrated improvements in all key areas. Their efficiency has increased, and the HPP has been able to generate additional electricity without increasing its water consumption. The impellers that we will install this year are also designed to increase efficiency at the HPP.”

The New Energy program, implemented at the Angara-Yenisei cascade HPPs (Ust-Ilimsk, Bratsk, Irkutsk and Krasnoyarsk), is a key investment project of En+ Group’s energy sector, which is worth RUB21 billion (US$283.7 million). The program as launched in 2007 and will run until 2046.One of the core priorities is to improve the reliability and safety of all stations. The comprehensive replacement of not only the main equipment like hydraulic units and impellers, but also auxiliary equipment, will be carried out under the program.

It is expected that, from 2022, En+ Group’s Siberian hydroelectric power plants will increase their electricity production by 2 billion kWh due to the program. This will reduce the group’s greenhouse gas emissions by 2.3 million tons per year.

Related Posts

Latest Hydro Review News